This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Thomas Tulip, PhD
Chief Technology Officer at Radiopharm Theranostics, Inc.

Agenda Sessions

  • Radiopharmaceutical Therapies: New Emerging Pillar in Oncology. What Challenges?

    2:00pm